Skip to main content
  • This website sets cookies on your device. To find out more about how we use cookies please refer to our Privacy and Cookie Policy. By continuing to use the site, we’ll assume that you are content for us to set these on your device.
  • Close
Home > Prudential Regulation Authority > Supervisory activities - Capital instruments: Pre-issuance notification (PIN)
 

Supervisory activities - Capital instruments: Pre-issuance notification (PIN)

Capital instruments  |  Climate Change Adaptation Reporting  |  Stress test scenario  |  Remuneration Rules  |  Run-off  |  Skilled Person Reviews  |  Stress testing

On this page you will find information on the pre-issuance notification (PIN) process including:
 
 
In accordance with the following Parts of the PRA Rulebook:
 
  • Chapter 7 of Definition of Capital;
  • Chapter 5 of Own Funds;
  • Chapter 6 of Group Supervision; and
  • Chapter 3 of Insurance Company – Capital Resources
 

Capital Requirements Regulation (CRR) firms (banks, building societies and PRA UK designated investment firms) and insurers (Solvency II firms and Non-Directive firms) must notify the Prudential Regulation Authority (PRA) prior to issuing most capital instruments that they intend to include in capital resources (Non-Directive Firms) or own funds (CRR firms and Solvency II firms), either at solo and/or (sub)consolidated level, by sending a completed Pre-Issuance Notification (PIN) form to the relevant email address available in ‘How to notify the PRA’. The PIN form is available under Key resources.


When to submit a PIN form

Firms should submit a PIN form prior to issuing any capital instrument that they intend to include in capital resources or own funds, either at solo, sub-consolidated or group consolidated level or any combination of the aforementioned.

In most cases, firms should submit the form at least one month prior to the intended date of issue (advance notification). However, the PRA may be prepared to accept less than one month’s notice in exceptional circumstances which make it impracticable to give one month’s notice. In such circumstances, a firm must submit an explanation on why it believes there are exceptional circumstances that mean the PRA should accept a shorter notice period, along with the PIN form as far in advance of the issuance as practicable in those circumstances. Firms may also submit a PIN form when the associated capital instrument’s date of issue is uncertain.

CRR firms and insurers may notify the PRA no later than the day of issuance of their intention to issue a capital instrument (ie same-day notification) if the conditions set out in the relevant Part of the PRA’s rules are fulfilled.

A summary table of the notification requirements and exemptions can be found here.
 
In addition to the PIN submission, firms are reminded that any new CET1 instruments issued after 28 June 2013 require a CRR Permission by the PRA before it can classify the instruments as CET1 capital. Once the firm has obtained a a CRR Art 26(3) permission from the PRA, the permission extends to all future issuances of capital instruments of the same type and which have the same characteristics as the instrument to which the permission relates. See CRR Permission page for more details on CRR Permission requirements.
 
Also, see Key Resources below for the flow charts on:
 
  1. the interaction between CRR Art 26(3) permission and PIN process for CET1 instruments; and
  2. PIN processes for Additional Tier (AT1) and Tier 2 instruments.

What to send to the PRA
 
If you are a CRR firm:
  • A completed PIN form for CRR firms  (available under Key resources);
  • A copy of the draft terms and conditions of the proposed own funds instrument;
  • For any item intended for inclusion within CET1 instruments, the terms of the instrument, eg the articles of association, together with any other relevant agreements, such as any shareholders agreement;
  • For any item intended for inclusion within Common Equity Tier 1 capital, the Common Equity Tier 1 Compliance Template (available under Key resources) completed by an appropriately qualified individual confirming that the capital instrument meets the conditions for qualification as Common Equity Tier 1 capital (in accordance with 7.4 of Definition of Capital);
  •  For any item intended for inclusion as Additional Tier 1 capital or Tier 2 capital, a draft of a properly reasoned independent legal opinion from an appropriately qualified individual confirming that the capital instrument meets the conditions for qualification as Additional Tier 1 capital or Tier 2 capital (in accordance with 7.3(3) of Definition of Capital);
  • For any item intended for inclusion within Additional Tier 1 capital, a draft of a properly reasoned independent accounting opinion by your auditor (in accordance with 7.2(4) of Definition of Capital); and
  • A written statement that you (intend to) comply with Articles 52(1) (a),(b) and (c) of the CRR (for Additional Tier 1 issuances) or Articles 63 (a),(b) and (c) of the CRR (for Tier 2 issuances).

If you are an insurer:
  • A completed PIN form for insurance firms (available under Key resources);
  •  A copy of the draft terms and conditions of the intended capital resources or own funds instrument;
  • For any item other than ordinary shares, a draft of a properly reasoned independent legal opinion from an appropriately qualified individual confirming that the capital instrument meets the conditions for qualification in the intended tier or stage of capital in accordance with Own Funds 5.2(2)(d) or Group Supervision 6.2(2)(f) (Solvency II firms) or Insurance Companies – Capital Resources 3.2(4) (non-Directive firms); and
  • For any item intended for inclusion within RT1 capital (for Solvency II firms), a draft of a properly reasoned independent accounting opinion from an appropriately qualified individual identifying the instrument’s treatment in the firm or group member’s financial statements in accordance with Own Funds 5.2(2)(e) or Group Supervision 6.2(2)(g).

How to notify the PRA

  • For CRR firms, the relevant PIN form (see Key Resources below) must be completed, signed on behalf of senior management, and sent to CRRFirms.regulatorycapital@bankofengland.co.uk.
  • For insurers, the relevant PIN form (see Key Resources below) must be completed, signed on behalf of the firm’s governing body, and sent to Insurance.regulatorycapital@bankofengland.co.uk.
  • Submission of the PIN form to a firm's PRA supervisory contact does not constitute the required notice. Firms may at their discretion copy their PRA supervisor when submitting the PIN form.

Frequently asked questions

  • Why is the PRA asking for this information?
  • Is Pre-Issuance Notification a form of PRA approval?
  • What happens if, during the notification period or before issuing the instrument, the information provided in the notification changes?
  • Does the notification requirement apply to capital issuances by entities that are not regulated by the PRA, which are intended to count as regulatory capital for a UK PRA-regulated group?
  • What happens if the firm wishes to amend the terms of the instrument?

Why is the PRA asking for this information?

  • to receive consistent data on the quality and quantity of own funds or capital resources issued by all firms;
  • to have advance notice of any proposed action that would result in a change in a particular firm’s capital position; and
  • to ensure firms have conducted appropriate governance with regard to satisfying themselves that capital items that they intend to count towards satisfying own funds or capital resources requirements meet relevant rules and PRA expectations regarding capital quality.

Is Pre-Issuance Notification a form of PRA approval?

No. PIN is not a pre-approval process and the PRA will not provide, nor should we be deemed to be providing, approval (whether explicit or implicit) of any instruments, or confirmation of their eligibility for inclusion in a particular tier of regulatory capital. CRR firms and insurers will continue to be responsible for ensuring that their instruments comply with all relevant rules and PRA expectations regarding quality of capital.
 

What happens if, during the notification period or before issuing the instrument, the information provided in the notification changes?

If the information provided in the notification changes, the firm must provide a further notification to the PRA, as soon as it proposes the change, making clear the nature of the amendment(s) or, alternatively, start the notification process anew. Minor amendments (for example, an amendment to the size of issuance or to the issue date) require an amendment to the notification. Where a significant change occurs, (for example, a change in the intended tier of capital or the introduction of new features) firms will need to restart the notification process. If you are unclear about whether to amend or restart notification, please speak with your PRA supervisory contact.
 

Does the notification requirement apply to capital issuances by entities that are not regulated by the PRA, which are intended to count as regulatory capital for a UK PRA-regulated group?

Yes. We are aware that a UK firm may not always be aware of plans to issue capital at a group level in a timely manner. Therefore, groups with a UK ultimate parent must notify us as soon as they become aware that a direct or indirect subsidiary of that UK parent (including an overseas subsidiary) that is not regulated by the PRA, plans to issue capital that the group will count as regulatory capital at the consolidated level. In addition, where an EEA insurance group is a sub-group of a wider non-EEA group, pre-issuance notification will only be required for capital issuances intended to count toward group capital requirements at the EEA sub-group level.
 

What happens if the firm wishes to amend the terms of the instrument? 


A firm is required to notify the PRA of its intention to amend or vary the terms of any capital instruments included in its own funds at least thirty days before the intended date of such amendment (PRA Rulebook Definition of Capital Part Rule 8). The PRA will evaluate whether the proposed changes would affect the eligibility of the instrument and, in the case of a CET1 instrument for CRR firms, whether the CRR Art 26(3) permission granted would still be valid.

Share